To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome - requiring regular injections or an insulin pump, continuous glucose monitoring and/or finger sticks to test one's blood sugar levels. For many of the 1.9 million Americans with the condition, that might be about to change. Researchers at UC San Francisco are exploring how two recently approved immunotherapy treatments could be expanded to treat type 1 diabetes more broadly.

https://www.miragenews.com/can-what-works-to-treat-cancer-work-for-diabetes-1080170/

#miragenews